Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong
· Delayed Price · Currency is HKD 5.10
+0.03 (0.59%)
Apr 28, 2026, 1:35 PM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.13 billion as of April 29, 2026. Its market cap has decreased by -8.59% in one year.
Market Cap
3.13B
Enterprise Value
3.45B
Revenue
14.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.13B, a decrease of -74.15%. That is a compound annual growth rate of -28.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.13B | 26.75% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 3.07B |
| Medtide | 3.00B |
| Antengene Corporation | 3.44B |
| BioDlink International Company | 3.49B |
| Viva Biotech Holdings | 3.61B |
| Mirxes Holding Company | 3.66B |
| Clover Biopharmaceuticals | 3.71B |
| TYK Medicines | 3.89B |